Skip to main content
. 2018 Jun 22;3(3):e000828. doi: 10.1136/bmjgh-2018-000828

Table 2.

Availability of medicines

Wealth quintile P values
Q1
(poorest)
Q2 Q3 Q4 Q5
(least poor)
Distance to health facilities (km)
 Nearest facility 8.11 (1.56) 9.01 (1.33) 5.25 (0.93) 5.88 (1.46) 5.22 (1.22) 0.050
 Nearest public facility 10.98 (1.48) 12.89 (1.67) 9.69 (1.27) 10.52 (2.05) 9.44 (1.36) 0.285
 Nearest non-profit facility 13.56 (2.20) 12.59 (1.88) 6.95 (0.87) 7.92 (1.27) 6.70 (1.09) 0.002
Probability nearest facility is public 0.54 (0.08) 0.37 (0.08) 0.30 (0.07) 0.30 (0.07) 0.29 (0.07) 0.020
Probability medicine available at nearest facility
 HCTZ (hypertension) 0.20 (0.07) 0.25 (0.08) 0.20 (0.07) 0.22 (0.07) 0.27 (0.09) 0.624
 Metformin (diabetes) 0.73 (0.08) 0.71 (0.08) 0.67 (0.10) 0.75 (0.08) 0.74 (0.08) 0.752
 Salbutamol inhaler (asthma) 0.38 (0.08) 0.37 (0.09) 0.57 (0.09) 0.43 (0.09) 0.55 (0.09) 0.109
Probability medicine purchased in private sector
 Hypertension 0.49 (0.06) 0.40 (0.07) 0.50 (0.06) 0.59 (0.06) 0.67 (0.05) 0.009
 Diabetes 0.41 (0.12) 0.32 (0.09) 0.48 (0.10) 0.50 (0.09) 0.61 (0.09) 0.042
 Asthma 0.36 (0.07) 0.45 (0.09) 0.65 (0.11) 0.72 (0.09) 0.67 (0.11) 0.001

All data are mean values with SD provided in parentheses.

HCTZ, hydrochlorothiazide.